NIH RFA · NHLBI · R35
RFA-HL-26-002: NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The OIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The OIA will support the research program of NHLBI-funded…
- NOFO number
- RFA-HL-26-002
- Type
- RFA
- Activity code
- R35
- Primary institute
- NHLBI · National Heart, Lung, and Blood Institute
- Clinical trials
- Optional
- Posted
- Apr 26, 2024
- Opens
- Jan 19, 2025
- Expires
- Apr 29, 2027
Projects funded under RFA-HL-26-002
NIH RePORTER lists 15 projects funded under RFA-HL-26-002 in FY2022–FY2026, with $15.7M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
15
Distinct projects, FY2022–FY2026
New awards
15
Type 1 (new project) award records
NIH funding
$15.7M
Award dollars under RFA-HL-26-002, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 15 | 15 | $15.7M |
Institutions with the most funding
- Columbia University Health Sciences$3.4M · 3 projects
- University of Pittsburgh at Pittsburgh$1.8M · 2 projects
- Brigham and Women's Hospital$1.2M · 1 project
- University of Washington$1.2M · 1 project
- University of Pennsylvania$1.1M · 1 project
- Ohio State University$1.1M · 1 project
- University of California, San Francisco$1.1M · 1 project
- Univ of North Carolina Chapel Hill$1.1M · 1 project
Funding institutes
- NHLBI$15.7M · 15
Activity codes funded
- R3515 records
Most recent new awards
- Interorganellar Calcium Signaling in Health and Disease (opens NIH RePORTER)
University of Pittsburgh at Pittsburgh · 1R35HL183468-01 · NHLBI · Notice Jul 28, 2026
$1.1MR35
- Decoding the enigma of cardiac arrhythmia and mechanosensitivity (opens NIH RePORTER)
University of Arizona · 1R35HL184262-01 · NHLBI · Notice Jul 3, 2026
$558KR35
- Screening and validation of miRNA targets for neurogenic hypertension. (opens NIH RePORTER)
LSU Health Sciences Center · 1R35HL184169-01 · NHLBI · Notice Apr 7, 2026
$1.0MR35
- The protein C pathway: Mechanisms, Structure-function, and Translation (opens NIH RePORTER)
Scripps Research Institute, the · 1R35HL184173-01 · NHLBI · Notice Apr 3, 2026
$864KR35
- Dynamics and plasticity of the hematopoietic stem cell niche (opens NIH RePORTER)
Columbia University Health Sciences · 1R35HL184177-01 · NHLBI · Notice Mar 31, 2026
$1.1MR35
- Therapeutic editing for cardiovascular diseases (opens NIH RePORTER)
University of Pennsylvania · 1R35HL183558-01 · NHLBI · Notice Mar 20, 2026
$1.1MR35
What its predecessor RFA-HL-23-004 funded
RFA-HL-26-002 reissues RFA-HL-23-004. Its funding history is the best guide to who wins under this program: 36 projects and $102.9M in FY2022–FY2026.
Projects funded
36
Distinct projects, FY2022–FY2026
New awards
36
Type 1 (new project) award records
NIH funding
$102.9M
Award dollars under RFA-HL-23-004, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 10 | 10 | $10.3M |
| FY2024 | 21 | 12 | $22.4M |
| FY2025 | 34 | 14 | $35.5M |
| FY2026 | 33 | 0 | $34.8M |
Institutions with the most funding
- Cincinnati Childrens Hosp Med Ctr$9.9M · 3 projects
- University of Michigan at Ann Arbor$7.9M · 3 projects
- Columbia University Health Sciences$7.8M · 2 projects
- University of Pennsylvania$5.6M · 2 projects
- University of California Los Angeles$5.4M · 2 projects
- Northwestern University$5.4M · 2 projects
- Boston Children's Hospital$4.9M · 1 project
- Washington University$4.4M · 2 projects
Funding institutes
- NHLBI$102.9M · 98
Activity codes funded
- R3598 records
Most recent new awards
- Regulation of Intravascular Triglyceride Hydrolysis (opens NIH RePORTER)
University of California Los Angeles · 1R35HL176438-01 · NHLBI · Notice Jul 23, 2025
$1.1MR35
- CD4+ T cell Immunity in the Respiratory Tract (opens NIH RePORTER)
Tulane University of Louisiana · 1R35HL177381-01 · NHLBI · Notice Jun 5, 2025
$1.1MR35
- The role of cancer in cardiovascular disease (opens NIH RePORTER)
Stanford University · 1R35HL176060-01 · NHLBI · Notice Apr 21, 2025
$1.1MR35
- Promoting weight-related health in the next generation of adolescents and young adults:A comprehensive program of research (opens NIH RePORTER)
University of Minnesota · 1R35HL177136-01 · NHLBI · Notice Apr 15, 2025
$1.1MR35
- Intersection of the PPARγ-RhoBTB1-Cullin-3 Pathway and Renin-Angiotensin System in Blood Pressure, Vascular Function and Arterial Stiffness (opens NIH RePORTER)
Medical College of Wisconsin · 1R35HL177123-01 · NHLBI · Notice Apr 15, 2025
$1.1MR35
- Advancing Precision Medicine for ARDS and Sepsis (opens NIH RePORTER)
University of California, San Francisco · 1R35HL177135-01 · NHLBI · Notice Apr 1, 2025
$1.1MR35
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under RFA-HL-26-002. Contact the program officer at the institute that fits your research before applying.
- NHLBI · National Heart, Lung, and Blood Institute
- none
Related notices
Mar 31, 2025
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.
Apr 4, 2024 · NOT-OD-24-084
Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025.
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- New The OER Glossary and the How to Apply - Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Applications may request up to 700,000 direct costs per year. Investigators are encouraged to request what is well-justified for their research program. The award amount will be determined by the NHLBI and commensurate with current NHLBI support of the PD/PI.
- Project period
- Applications may request a maximum project period of up to seven 7) years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.The NHLBI intends to commit up to 20 million per year in total costs for new awards in Fiscal Years 2026, 2027, and 2028, across this NOFO and the companion NOFO listed RFA-HL-26-003).The NHLBI intends to fund up to 20 new R35 awards per year in Fiscal Years 2026, 2027,…
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of RFA-HL-23-004.
- Companion NOFOs: RFA-HL-26-003.
Other open NOFOs for R35
- RFA-HL-26-003NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)NHLBI
- PAR-26-121Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)NIGMS · next due Jan 27, 2027
- PAR-27-032Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)NIGMS
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.